Puma Biotechnology Inc (PBYI) (Q3 2026) Earnings Call Highlights: Debt-Free and Raising ...
Puma Biotechnology Inc (PBYI) lifted its full-year 2026 net income outlook to $20-$22 million while advancing alisertib trials and posting $54.1 million in quarterly net product revenue. Related Stocks: PBYI ,